• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Substance P receptors are differentially affected in Parkinson's and Alzheimer's disease.

作者信息

Rioux L, Joyce J N

机构信息

Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia.

出版信息

J Neural Transm Park Dis Dement Sect. 1993;6(3):199-210. doi: 10.1007/BF02260922.

DOI:10.1007/BF02260922
PMID:7510109
Abstract

We have quantified by receptor autoradiography the number of NK1 receptors, using [125I] Bolton-Hunter labeled substance P, in striatum and pallidum (internal (GPi) or external (GPe) segment) of patients suffering from Alzheimer's (AD) and Parkinson's disease (PD). When compared to non-neurologic controls, a significant increase in the number of NK1 sites has been observed in the striatum of PD patients. No significant differences were observed for the GPi and GPe. We observed no significant differences from controls in the number of NK1 sites in the striatum and pallidum of AD cases. However, the number of NK1 sites in the striatum of AD patients was significantly lower than that of PD patients. These results show that the expression of NK1 receptors in the basal ganglia is affected in PD.

摘要

相似文献

1
Substance P receptors are differentially affected in Parkinson's and Alzheimer's disease.
J Neural Transm Park Dis Dement Sect. 1993;6(3):199-210. doi: 10.1007/BF02260922.
2
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.路易体痴呆、帕金森病和阿尔茨海默病中基底神经节的毒蕈碱受体
J Chem Neuroanat. 2003 Mar;25(3):161-73. doi: 10.1016/s0891-0618(03)00002-4.
3
Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease.帕金森病和阿尔茨海默病尸检组织中基底神经节和新皮质中铁的分布。
Dementia. 1993 Mar-Apr;4(2):61-5. doi: 10.1159/000107298.
4
The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease.阿尔茨海默病患者纹状体内β淀粉样蛋白沉积的分布情况。
Neuropathol Appl Neurobiol. 1997 Aug;23(4):322-5.
5
Pallidal gap junctions-triggers of synchrony in Parkinson's disease?苍白球缝隙连接——帕金森病同步性的触发因素?
Mov Disord. 2014 Oct;29(12):1486-94. doi: 10.1002/mds.25987. Epub 2014 Aug 13.
6
Reduced [125I]-Bolton Hunter substance P binding (NK1 receptors) in the basal forebrain nuclei of aged rats.老年大鼠基底前脑核中[125I]-博尔顿·亨特P物质结合(NK1受体)减少。
Clin Exp Pharmacol Physiol. 2002 Dec;29(12):1112-5. doi: 10.1046/j.1440-1681.2002.03781.x.
7
Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease.帕金森叠加型阿尔茨海默病中多巴胺D2受体缺失,但帕金森病或阿尔茨海默病中无此现象。
Neuropsychopharmacology. 1998 Dec;19(6):472-80. doi: 10.1016/S0893-133X(98)00044-X.
8
Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases.
Brain Res. 1989 May 8;486(2):387-90. doi: 10.1016/0006-8993(89)90529-5.
9
Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.MPTP 处理的猴子基底神经节中多巴胺受体和神经肽表达的调节
Exp Neurol. 2004 Oct;189(2):393-403. doi: 10.1016/j.expneurol.2004.05.041.
10
Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain.
J Neural Transm (Vienna). 2003 Nov;110(11):1279-88. doi: 10.1007/s00702-003-0033-7.

引用本文的文献

1
Quantification of central substance P receptor occupancy by aprepitant using small animal positron emission tomography.使用小动物正电子发射断层扫描技术对阿瑞匹坦引起的中枢P物质受体占有率进行定量分析。
Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu030. doi: 10.1093/ijnp/pyu030.
2
Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link.速激肽与神经激肽受体在骨髓功能中的作用:神经 - 造血联系
J Receptor Ligand Channel Res. 2010 Apr 1;2010(3):51-61. doi: 10.2147/jrlcr.s6509.
3
Neurokinin-1 receptor activation in globus pallidus.
苍白球中神经激肽-1受体的激活
Front Neurosci. 2009 Oct 26;3:58. doi: 10.3389/neuro.23.002.2009. eCollection 2009.
4
PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibility.[(18)F]SPA-RQ对人体神经激肽-1受体的PET成像:参考组织模型评估及其重测可重复性
Synapse. 2007 Apr;61(4):242-51. doi: 10.1002/syn.20361.
5
Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.速激肽NK1拮抗剂放射性配体[18F]SPA-RQ的人体生物分布及辐射剂量测定:薄层、对半切开及二维平面图像分析的比较
J Nucl Med. 2007 Jan;48(1):100-7.